<?xml version="1.0" encoding="UTF-8"?>
<ref id="B78-molecules-25-04588">
 <label>78.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chen</surname>
    <given-names>Y.S.</given-names>
   </name>
   <name>
    <surname>Lai</surname>
    <given-names>C.C.</given-names>
   </name>
   <name>
    <surname>Kuo</surname>
    <given-names>Y.P.</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>I.S.</given-names>
   </name>
   <name>
    <surname>Yen</surname>
    <given-names>C.H.</given-names>
   </name>
  </person-group>
  <article-title>Identification of compound isolated from 
   <italic>Beilschmiedia tsangii</italic> as a liver cancer specific NRF2 inhibitor. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1â€“5; Washington, DC. Philadelphia (PA): AACR
  </article-title>
  <source>Cancer Res.</source>
  <year>2017</year>
  <volume>77</volume>
  <fpage>Abstract nr 190</fpage>
 </element-citation>
</ref>
